Investors

Introduction

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system (LUNAR™) and UNA Oligomer chemistry technologies.

The Investor Relations section is designed to provide easy access to company information.

NASDAQ: ARCT

$ 9.00

12:12 PM | Nov 21, 2017
+$0.20
(2.27%)

Day High: 9.09
Day Low:  8.65
Volume:    27,329
Delayed ~20 min., by eSignal.